These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35995334)

  • 1. Methylglyoxal - an advanced glycation end products (AGEs) precursor - Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE).
    Waqas K; Muller M; Koedam M; El Kadi Y; Zillikens MC; van der Eerden BCJ
    Bone; 2022 Nov; 164():116526. PubMed ID: 35995334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
    Phimphilai M; Pothacharoen P; Kongtawelert P
    Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts.
    Park SY; Choi KH; Jun JE; Chung HY
    J Korean Med Sci; 2021 Sep; 36(37):e239. PubMed ID: 34581519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis.
    Sun Y; Zhu Y; Liu X; Chai Y; Xu J
    Cell Prolif; 2020 Aug; 53(8):e12866. PubMed ID: 32643284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that methylglyoxal and receptor for advanced glycation end products are implicated in bladder dysfunction of obese diabetic
    Oliveira AL; Medeiros ML; Ghezzi AC; Dos Santos GA; Mello GC; Mónica FZ; Antunes E
    Am J Physiol Renal Physiol; 2023 Oct; 325(4):F436-F447. PubMed ID: 37560771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
    Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
    J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products affect growth and function of osteoblasts.
    Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G
    Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of advanced glycation end products on autophagic ability in osteoblasts.
    Luo D; Hu Y; Tang Y; Ding X; Li C; Zheng L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):361-367. PubMed ID: 33967081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway.
    Zhang M; Li Y; Rao P; Huang K; Luo D; Cai X; Xiao J
    Cell Prolif; 2018 Oct; 51(5):e12471. PubMed ID: 30014569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes.
    Phimphilai M; Pothacharoen P; Chattipakorn N; Kongtawelert P
    Front Endocrinol (Lausanne); 2022; 13():799872. PubMed ID: 35237235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts.
    Franke S; Siggelkow H; Wolf G; Hein G
    Arch Physiol Biochem; 2007 Jun; 113(3):154-61. PubMed ID: 17922311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
    Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
    BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells.
    Manfredelli D; Pariano M; Costantini C; Graziani A; Bozza S; Romani L; Puccetti P; Talesa VN; Antognelli C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
    Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
    Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100b treatment overcomes RAGE signaling deficits in myoblasts on advanced glycation end-product cross-linked collagen and promotes myogenic differentiation.
    Olson LC; Nguyen T; Sabalewski EL; Puetzer JL; Schwartz Z; McClure MJ
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1080-C1093. PubMed ID: 38314727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired osteogenic differentiation and enhanced cellular receptor of advanced glycation end products sensitivity in patients with type 2 diabetes.
    Phimphilai M; Pothacharoen P; Kongtawelert P; Chattipakorn N
    J Bone Miner Metab; 2017 Nov; 35(6):631-641. PubMed ID: 27873077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end-product 2 and Porphyromonas gingivalis lipopolysaccharide increase sclerostin expression in mouse osteocyte-like cells.
    Sakamoto E; Kido JI; Takagi R; Inagaki Y; Naruishi K; Nagata T; Yumoto H
    Bone; 2019 May; 122():22-30. PubMed ID: 30735798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescuing effects of periostin in advanced glycation end-products (AGEs) caused osteogenic and oxidative damage through AGE receptor mediation and DNA methylation of the CALCA promoter.
    Wang QN; Yan YZ; Zhang XZ; Lv JX; Nie HP; Wu J; Wu D; Yuan SS; Tang CB
    Chem Biol Interact; 2022 Feb; 354():109835. PubMed ID: 35090876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells.
    Suga T; Iso T; Shimizu T; Tanaka T; Yamagishi S; Takeuchi M; Imaizumi T; Kurabayashi M
    J Atheroscler Thromb; 2011; 18(8):670-83. PubMed ID: 21512281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.